Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

BACKGROUND: ‘No evidence of disease activity’ (NEDA), defined as absence of magnetic resonance imaging activity (T2 and/or gadolinium-enhanced T1 lesions), relapses and disability progression (‘NEDA-3’), is used as a comprehensive measure of treatment response in relapsing multiple sclerosis (RMS),...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mult Scler
Autori principali: Kappos, Ludwig, De Stefano, Nicola, Freedman, Mark S, Cree, Bruce AC, Radue, Ernst-Wilhelm, Sprenger, Till, Sormani, Maria Pia, Smith, Terence, Häring, Dieter A, Piani Meier, Daniela, Tomic, Davorka
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2015
Soggetti:
Original Research Papers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5015759/
https://ncbi.nlm.nih.gov/pubmed/26585439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458515616701
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi